drugset / Trial / NCT00097032

Study Measuring Differences in Cognition Due to Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I Outpatients

NCT00097032 ↗

RandomizedCrossoverDouble-blind

Summary

The purpose of this study is to determine whether the sedating (causing sleepiness) effects of risperidone or quetiapine alter cognitive (person's ability to think, perceive, recognize, remember, judge, and reason) functioning in subjects with stable Bipolar I Disorder.

Timeline

Start
2004-10
Primary completion
—
Completion
2005-05

Outcome

Met primary endpoint

paper On the NCS, significantly better overall cognitive function was seen after risperidone than after quetiapine at each time point after dosing. PMID 17854242 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Quetiapine Small molecule 100 mg —
Subject Risperidone Other / unclassified 2 mg —

Indications